Welcome to LookChem.com Sign In|Join Free

CAS

  • or

4619-20-9

Post Buying Request

4619-20-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

4619-20-9 Usage

Chemical Properties

White to light beige crystalline powder

Uses

3-(4-Methylbenzoyl)propionic acid can be used as an intermediate in agrochemical, pharmaceutical and dyestuff field

General Description

4-(4-Methylphenyl)-4-oxobutyric acid is an organic building block. It is a commercial corrosion inhibitor.

Check Digit Verification of cas no

The CAS Registry Mumber 4619-20-9 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 4,6,1 and 9 respectively; the second part has 2 digits, 2 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 4619-20:
(6*4)+(5*6)+(4*1)+(3*9)+(2*2)+(1*0)=89
89 % 10 = 9
So 4619-20-9 is a valid CAS Registry Number.
InChI:InChI=1/C11H12O3/c1-8-2-4-9(5-3-8)10(12)6-7-11(13)14/h2-5H,6-7H2,1H3,(H,13,14)

4619-20-9 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (A10290)  3-(4-Methylbenzoyl)propionic acid, 98%   

  • 4619-20-9

  • 5g

  • 436.0CNY

  • Detail
  • Alfa Aesar

  • (A10290)  3-(4-Methylbenzoyl)propionic acid, 98%   

  • 4619-20-9

  • 25g

  • 1744.0CNY

  • Detail
  • Alfa Aesar

  • (A10290)  3-(4-Methylbenzoyl)propionic acid, 98%   

  • 4619-20-9

  • 100g

  • 5741.0CNY

  • Detail

4619-20-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-(4-Methylbenzoyl)propionic acid

1.2 Other means of identification

Product number -
Other names 4-(4-methylphenyl)-4-oxobutanoic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:4619-20-9 SDS

4619-20-9Synthetic route

succinic acid anhydride
108-30-5

succinic acid anhydride

toluene
108-88-3

toluene

3-(4-methylbenzoyl)propionic acid
4619-20-9

3-(4-methylbenzoyl)propionic acid

Conditions
ConditionsYield
Stage #1: succinic acid anhydride With aluminum (III) chloride In dichloromethane at 20℃; for 0.0833333h; Schlenk technique; Sealed tube;
Stage #2: toluene In dichloromethane at 20℃; Schlenk technique; Sealed tube;
99%
With aluminum (III) chloride at 50 - 60℃; for 2h; Friedel-Crafts Acylation;99.3%
With aluminum (III) chloride at 60℃; Friedel-Crafts Acylation; Ionic liquid; Irradiation;95%
(E)-4-oxo-4-(p-tolyl)but-2-enoic acid
20972-36-5

(E)-4-oxo-4-(p-tolyl)but-2-enoic acid

3-(4-methylbenzoyl)propionic acid
4619-20-9

3-(4-methylbenzoyl)propionic acid

Conditions
ConditionsYield
With hydrogen; palladium In methanol at 20℃; for 10h;99%
With trifluoroacetic acid; lithium chloride In methanol Inert atmosphere; Electrolysis;
ethyl 4-oxo-4-(p-tolyl)butanoate
6942-61-6

ethyl 4-oxo-4-(p-tolyl)butanoate

3-(4-methylbenzoyl)propionic acid
4619-20-9

3-(4-methylbenzoyl)propionic acid

Conditions
ConditionsYield
Stage #1: ethyl 4-oxo-4-(p-tolyl)butanoate With sodium hydroxide In methanol at 20℃; for 3h;
Stage #2: With hydrogenchloride In water
97%
Methyl (E)-4-hydroxy-4-(4'-methylphenyl)but-2-enoate
78861-22-0

Methyl (E)-4-hydroxy-4-(4'-methylphenyl)but-2-enoate

3-(4-methylbenzoyl)propionic acid
4619-20-9

3-(4-methylbenzoyl)propionic acid

Conditions
ConditionsYield
With sodium hydroxide In ethanol; water for 1h; Heating;78%
Multi-step reaction with 3 steps
1: 91 percent / active MnO2 / CH2Cl2 / 3 h / Ambient temperature
2: NaBH4 / methanol; H2O / 1.) 5-10 deg C, 30 min , 2.) RT , 1 h
3: 78 percent / NaOH / ethanol; H2O / 1 h / Heating
View Scheme
5-(4-methylphenyl)-3H-furan-2-one
21053-98-5

5-(4-methylphenyl)-3H-furan-2-one

thioacetamide
62-55-5

thioacetamide

3-(4-methylbenzoyl)propionic acid
4619-20-9

3-(4-methylbenzoyl)propionic acid

Conditions
ConditionsYield
at 120 - 130℃; for 4h;45%
Methyl 3-bromo-4-keto-4-(4'-methylphenyl)butanoate
78861-19-5

Methyl 3-bromo-4-keto-4-(4'-methylphenyl)butanoate

3-(4-methylbenzoyl)propionic acid
4619-20-9

3-(4-methylbenzoyl)propionic acid

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 31 percent / NaBH4, NaHCO3 / methanol; H2O / 1.5 h / 28 °C
2: 78 percent / NaOH / ethanol; H2O / 1 h / Heating
View Scheme
Multi-step reaction with 4 steps
1: 31 percent / NaBH4, NaHCO3 / methanol; H2O / 1.5 h / 28 °C
2: 91 percent / active MnO2 / CH2Cl2 / 3 h / Ambient temperature
3: NaBH4 / methanol; H2O / 1.) 5-10 deg C, 30 min , 2.) RT , 1 h
4: 78 percent / NaOH / ethanol; H2O / 1 h / Heating
View Scheme
4-methyl-benzoyl chloride
874-60-2

4-methyl-benzoyl chloride

3-(4-methylbenzoyl)propionic acid
4619-20-9

3-(4-methylbenzoyl)propionic acid

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: copper(I) cyanide di(lithium chloride) / tetrahydrofuran / 3 h / -15 - 20 °C / Inert atmosphere
2: sodium hydroxide / methanol / 3 h / 20 °C
View Scheme
C11H13NO3

C11H13NO3

3-(4-methylbenzoyl)propionic acid
4619-20-9

3-(4-methylbenzoyl)propionic acid

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: hydrogen; palladium 10% on activated carbon / ethyl acetate / 24 h / 20 °C
2: ω-transaminase from Burkholderia graminis C4D1M; piruvate; pyridoxal 5'-phosphate / dimethyl sulfoxide / 24 h / pH 7.0 / Resolution of racemate; Enzymatic reaction
View Scheme
4-amino-4-(4-methoxyphenyl)butanoic acid

4-amino-4-(4-methoxyphenyl)butanoic acid

A

3-(4-methylbenzoyl)propionic acid
4619-20-9

3-(4-methylbenzoyl)propionic acid

B

(R)-4-amino-4-(4-methoxyphenyl)butanoic acid

(R)-4-amino-4-(4-methoxyphenyl)butanoic acid

Conditions
ConditionsYield
With pyridoxal 5'-phosphate; ω-transaminase from Burkholderia graminis C4D1M; piruvate In dimethyl sulfoxide for 24h; pH=7.0; Reagent/catalyst; Resolution of racemate; Enzymatic reaction;A n/a
B n/a
succinic acid anhydride
108-30-5

succinic acid anhydride

para-methylphenylmagnesium bromide
4294-57-9

para-methylphenylmagnesium bromide

3-(4-methylbenzoyl)propionic acid
4619-20-9

3-(4-methylbenzoyl)propionic acid

Conditions
ConditionsYield
Stage #1: succinic acid anhydride; para-methylphenylmagnesium bromide With iron(III)-acetylacetonate In tetrahydrofuran at -40 - 20℃; Inert atmosphere;
Stage #2: With hydrogenchloride In water pH=Ca. 1; Inert atmosphere;
methanol
67-56-1

methanol

3-(4-methylbenzoyl)propionic acid
4619-20-9

3-(4-methylbenzoyl)propionic acid

methyl 4-(4-methylphenyl)-4-oxobutanoate
57498-54-1

methyl 4-(4-methylphenyl)-4-oxobutanoate

Conditions
ConditionsYield
With sulfuric acid at 70℃; for 5h;100%
With sulfuric acid at 68℃;99%
With sulfuric acid at 20℃; for 12h;99.4%
3-(4-methylbenzoyl)propionic acid
4619-20-9

3-(4-methylbenzoyl)propionic acid

sodium 3-(4'-methylbenzoyl)propanoate
220367-39-5

sodium 3-(4'-methylbenzoyl)propanoate

Conditions
ConditionsYield
With sodium hydrogencarbonate In ethanol; water99%
3-(4-methylbenzoyl)propionic acid
4619-20-9

3-(4-methylbenzoyl)propionic acid

potassium 3-(4'-methylbenzoyl)propanoate

potassium 3-(4'-methylbenzoyl)propanoate

Conditions
ConditionsYield
With potassium carbonate In ethanol; water99%
3-(4-methylbenzoyl)propionic acid
4619-20-9

3-(4-methylbenzoyl)propionic acid

(3aS,4aR,9bS)-3a-(p-tolyl)-3,3a,4a,9b-tetrahydro-5H-indeno[1,2-d]pyrrolo[2,1-b]oxazol-1(2H)-one

(3aS,4aR,9bS)-3a-(p-tolyl)-3,3a,4a,9b-tetrahydro-5H-indeno[1,2-d]pyrrolo[2,1-b]oxazol-1(2H)-one

Conditions
ConditionsYield
In toluene for 15h; Reflux; Dean-Stark;98%
ethanol
64-17-5

ethanol

3-(4-methylbenzoyl)propionic acid
4619-20-9

3-(4-methylbenzoyl)propionic acid

ethyl 4-oxo-4-(p-tolyl)butanoate
6942-61-6

ethyl 4-oxo-4-(p-tolyl)butanoate

Conditions
ConditionsYield
With toluene-4-sulfonic acid Reflux;96%
With hydrogenchloride at 25℃; for 15h;95%
With hydrogenchloride
With sulfuric acid
With hydrogenchloride In water at 20℃; for 4h;
3-(4-methylbenzoyl)propionic acid
4619-20-9

3-(4-methylbenzoyl)propionic acid

methylhydrazine
60-34-4

methylhydrazine

2-methyl-6-(4-methylphenyl)-4,5-dihydro-3(2H)-pyridazinone
483989-48-6

2-methyl-6-(4-methylphenyl)-4,5-dihydro-3(2H)-pyridazinone

Conditions
ConditionsYield
In acetic acid Heating;96%
3-(4-methylbenzoyl)propionic acid
4619-20-9

3-(4-methylbenzoyl)propionic acid

Cholestanol
80-97-7

Cholestanol

4-Oxo-4-p-tolyl-butyric acid (3S,5S,8R,9S,10S,13R,14S,17R)-17-((R)-1,5-dimethyl-hexyl)-10,13-dimethyl-hexadecahydro-cyclopenta[a]phenanthren-3-yl ester

4-Oxo-4-p-tolyl-butyric acid (3S,5S,8R,9S,10S,13R,14S,17R)-17-((R)-1,5-dimethyl-hexyl)-10,13-dimethyl-hexadecahydro-cyclopenta[a]phenanthren-3-yl ester

Conditions
ConditionsYield
With polystyryl diphenyl phosphine-iodine In dichloromethane at 40 - 50℃; for 0.833333h;96%

4619-20-9Relevant articles and documents

Linear free energy relationships of half-wave reduction potentials of (E)-4-aryl-4-oxo-2-butenoic acids

Pastor, Ferenc T.,Drakuli?, Branko J.

, p. 734 - 738 (2010)

Half-wave reduction potentials of a set of twelve (E)-4-aryl-4-oxo-2-butenoic acids obtained by direct current polarography in methanol are reported. E1/2 is correlated with Hammett sigma values as well as with values of frontier molecular orbitals calculated at a semiempirical molecular orbital level. Constant potential electrolysis of a representative compound shows that the first polarographic wave corresponds to one-electron reduction. The isolation of the product proves reduction of the activated double bond.

In silico designing, in vitro and in vivo evaluation of potential PPAR-γ agonists derived from aryl propionic acid scaffold

Kharbanda, Chetna,Alam, Mohammad Sarwar,Hamid, Hinna,Ali, Yakub,Nazreen, Syed,Dhulap, Abhijeet,Alam, Perwez,Pasha

, (2020/11/27)

Attributed to several side effects, especially on hepatic tissues and body weight, there is always an urge of innovation and upgrading in already existing medication being used in maintaining diabetic condition. Therefore, in the present work, forty-eight molecules derived from arylpropionic acid scaffold were synthesized and their evaluation against diabetes was carried out. The synthesis of these molecules attributed to excellent dock score displayed by all the structures performed against PPAR-γ receptor site. Subsequently, all the derivatives were primarily deduced for their antidiabetic potential by OGTT. The compounds that showed significant antidiabetic activity in OGT Test and also exhibited high dock scores were assessed further by in vitro PPAR transactivation assay to assure analogy between in vivo and in vitro studies. The antidiabetic activity of these active compounds was then evaluated on STZ induced diabetic model in vivo. The most active compounds were scrutinized for its effect on PPAR-γ gene expression and hepatotoxic effect. Finally, it was recapitulated that these derivatives can provide a new prospect towards the development of antidiabetic agents with fewer side effects.

Direct Synthesis of Chiral NH Lactams via Ru-Catalyzed Asymmetric Reductive Amination/Cyclization Cascade of Keto Acids/Esters

Shi, Yongjie,Tan, Xuefeng,Gao, Shuang,Zhang, Yao,Wang, Jingxin,Zhang, Xumu,Yin, Qin

supporting information, p. 2707 - 2713 (2020/03/30)

Lactams with a stereogenic center adjacent to the N atom have existed in many medicinal agents and bioactive alkaloids. Herein we report a broadly applicable synthesis of enantioenriched NH lactams through a one-pot asymmetric reductive amination/cyclization sequence of easily available keto acids/esters. Such cascade processes alleviate the demand for protecting group manipulations as well as intermediate purification. This strategy is capable of constructing enantioenriched lactams and benzo-lactams of a five-, six-, or seven-membered ring in generally high yield and with excellent enantioselectivities (up to 97% ee). Scalable and concise syntheses of key drug intermediates have further displayed the importance of this methodology.

Iridium-Catalyzed Asymmetric Hydrogenation of ?- A nd ?-Ketoacids for Enantioselective Synthesis of ?- A nd ?-Lactones

Hua, Yun-Yu,Bin, Huai-Yu,Wei, Tao,Cheng, Hou-An,Lin, Zu-Peng,Fu, Xing-Feng,Li, Yuan-Qiang,Xie, Jian-Hua,Yan, Pu-Cha,Zhou, Qi-Lin

supporting information, p. 818 - 822 (2020/02/15)

A highly efficient asymmetric hydrogenation of ?- A nd ?-ketoacids was developed by using a chiral spiro iridium catalyst (S)-1a, affording the optically active ?- A nd ?-hydroxy acids/lactones in high yields with excellent enantioselectivities (up to >99% ee) and turnover numbers (TON up to 100000). This protocol provides an efficient and practical method for enantioselective synthesis of Ezetimibe.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 4619-20-9